HLB Science (XKRX:343090) ROCE % : -68.48% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HLB Science's annualized ROCE % for the quarter that ended in Dec. 2024 was -68.48%.

HLB Science ROCE % Historical Data

The historical data trend for HLB Science's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science ROCE % Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Dec24

ROCE %

-68.48

HLB Science Semi-Annual Data
	Dec22	Dec23	Dec24
ROCE %	-	-	-68.48

HLB Science ROCE % Calculation

HLB Science's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-2078.777	/	( ( (3950.314 - 512.391)	+	(4903.119 - 2269.909) )	/ 2 )
	=	-2078.777	/	( (3437.923	+	2633.21)	/ 2 )
	=	-2078.777	/	3035.5665
	=	-68.48 %

HLB Science's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Dec. 2023 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Dec. 2023 )		(Q: Dec. 2024 )
	=	-2078.777	/	( ( (3950.314 - 512.391)	+	(4903.119 - 2269.909) )	/ 2 )
	=	-2078.777	/	( ( 3437.923	+	2633.21 )	/ 2 )
	=	-2078.777	/	3035.5665
	=	-68.48 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

HLB Science (XKRX:343090) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HLB Science ROCE % Related Terms

Thank you for viewing the detailed overview of HLB Science's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science Headlines

No Headlines